메뉴 건너뛰기




Volumn 91, Issue 2, 2010, Pages 342-344

Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; PREDNISONE; RITUXIMAB; VINCRISTINE;

EID: 77950916178     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0522-z     Document Type: Letter
Times cited : (7)

References (12)
  • 1
    • 39749182212 scopus 로고    scopus 로고
    • A decade of rituximab: Improving survival outcomes in non-Hodgkin's lymphoma
    • DOI 10.1146/annurev.med.59.060906.220345
    • A Molina 2008 A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma Annu Rev Med 59 237 250 10.1146/annurev.med.59.060906. 220345 1:CAS:528:DC%2BD1cXis12nur4%3D 18186705 (Pubitemid 351291630)
    • (2008) Annual Review of Medicine , vol.59 , pp. 237-250
    • Molina, A.1
  • 2
    • 0037105369 scopus 로고    scopus 로고
    • Rituximab treatment results in impaired secondary humoral immune responsiveness
    • 12200395
    • LE van der Kolk JW Baars MH Prins MH van Oers 2002 Rituximab treatment results in impaired secondary humoral immune responsiveness Blood 100 2257 2259 12200395
    • (2002) Blood , vol.100 , pp. 2257-2259
    • Van Der Kolk, L.E.1    Baars, J.W.2    Prins, M.H.3    Van Oers, M.H.4
  • 3
    • 70350566122 scopus 로고    scopus 로고
    • Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
    • 10.1007/s12185-009-0359-5 1:CAS:528:DC%2BD1MXotV2qt7o%3D 19544079
    • S Kusumoto Y Tanaka M Mizokami R Ueda 2009 Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma Int J Hematol 90 13 23 10.1007/s12185-009-0359-5 1:CAS:528:DC%2BD1MXotV2qt7o%3D 19544079
    • (2009) Int J Hematol , vol.90 , pp. 13-23
    • Kusumoto, S.1    Tanaka, Y.2    Mizokami, M.3    Ueda, R.4
  • 4
    • 70350066135 scopus 로고    scopus 로고
    • Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier
    • 10.1093/annonc/mdp230 1:STN:280:DC%2BD1MjntFKlug%3D%3D 19561036
    • N Fukushima T Mizuta M Tanaka M Yokoo M Ide T Hisatomi, et al. 2009 Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier Ann Oncol 20 2013 2017 10.1093/annonc/mdp230 1:STN:280:DC%2BD1MjntFKlug%3D%3D 19561036
    • (2009) Ann Oncol , vol.20 , pp. 2013-2017
    • Fukushima, N.1    Mizuta, T.2    Tanaka, M.3    Yokoo, M.4    Ide, M.5    Hisatomi, T.6
  • 6
    • 0026088152 scopus 로고
    • Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study
    • 1:STN:280:DyaK3M%2FmtVSiuw%3D%3D 1983820
    • AS Lok RH Liang EK Chiu KL Wong TK Chan D Todd 1991 Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 100 182 188 1:STN:280: DyaK3M%2FmtVSiuw%3D%3D 1983820
    • (1991) Gastroenterology , vol.100 , pp. 182-188
    • Lok, A.S.1    Liang, R.H.2    Chiu, E.K.3    Wong, K.L.4    Chan, T.K.5    Todd, D.6
  • 7
    • 59149085061 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without Rituximab
    • 10.1200/JCO.2008.18.0182 1:CAS:528:DC%2BD1MXivFyju7s%3D 19075267
    • W Yeo TC Chan NW Leung WY Lam FK Mo MT Chu, et al. 2009 Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without Rituximab J Clin Oncol 27 605 611 10.1200/JCO.2008.18.0182 1:CAS:528:DC%2BD1MXivFyju7s%3D 19075267
    • (2009) J Clin Oncol , vol.27 , pp. 605-611
    • Yeo, W.1    Chan, T.C.2    Leung, N.W.3    Lam, W.Y.4    Mo, F.K.5    Chu, M.T.6
  • 8
    • 28944442419 scopus 로고    scopus 로고
    • Therapeutic implications of hepatitis B virus genotypes
    • DOI 10.1111/j.1478-3231.2005.01177.x
    • CJ Liu JH Kao DS Chen 2005 Therapeutic implications of hepatitis B virus genotypes Liver Int 25 1097 1107 10.1111/j.1478-3231.2005.01177.x 1:CAS:528:DC%2BD28XkslSktA%3D%3D 16343058 (Pubitemid 41782551)
    • (2005) Liver International , vol.25 , Issue.6 , pp. 1097-1107
    • Liu, C.-J.1    Kao, J.-H.2    Chen, D.-S.3
  • 9
    • 55549094415 scopus 로고    scopus 로고
    • Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma
    • 10.3324/haematol.13750 1:STN:280:DC%2BD1cjhtFKnsQ%3D%3D 18978292
    • C Targhetta MG Cabras E Angelucci 2008 Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma Haematologica 93 e66 10.3324/haematol.13750 1:STN:280:DC%2BD1cjhtFKnsQ%3D%3D 18978292
    • (2008) Haematologica , vol.93 , pp. 66
    • Targhetta, C.1    Cabras, M.G.2    Angelucci, E.3
  • 11
    • 60649087211 scopus 로고    scopus 로고
    • From a medical mistake to a clinical warning: The case of HBV mutant virus reactivation in haematological patients
    • 10.1111/j.1365-2141.2008.07539.x 19120363
    • G Zoppoli B Bruzzone P Caligiuri A Picciotto E Balleari A Bruzzone, et al. 2009 From a medical mistake to a clinical warning: the case of HBV mutant virus reactivation in haematological patients Br J Haematol 144 969 970 10.1111/j.1365-2141.2008.07539.x 19120363
    • (2009) Br J Haematol , vol.144 , pp. 969-970
    • Zoppoli, G.1    Bruzzone, B.2    Caligiuri, P.3    Picciotto, A.4    Balleari, E.5    Bruzzone, A.6
  • 12
    • 33846972329 scopus 로고    scopus 로고
    • Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies
    • DOI 10.1111/j.1365-2141.2006.06465.x
    • G Lalazar D Rund D Shouval 2007 Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies Br J Haematol 136 699 712 10.1111/j.1365-2141.2006.06465.x 1:CAS:528: DC%2BD2sXjvFWmtb0%3D 17338776 (Pubitemid 46246304)
    • (2007) British Journal of Haematology , vol.136 , Issue.5 , pp. 699-712
    • Lalazar, G.1    Rund, D.2    Shouval, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.